Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study

Jane N. Winter, MD, Fangxin Hong, PhD, Lisa M. Rimsza, MD, Michael LeBlanc, Ph.D., Daina Variakojis, M.D., Maryla Krajewska, M.D., Thomas M. Habermann, MD, Ari Melnick, MD, James K. Weick, MD, Frederick Pollock, Ihab Botros, Ph.D., John C. Reed, MD, PhD, Richard I Fisher, MD, Brad S. Kahl, MD, Sandra J. Horning, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 87.

https://doi.org/10.1182/blood.V118.21.87.87

Published: 2011

Journal Articles

Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay

David T Yang, MD, Gene R Shaw, MD, PhD, Kreg M Grindle, Songwon Seo, Catherine Leith, MBBChir, Ken H Young, Brad Kahl, MD

Blood (2010) 116 (21): 2007.

https://doi.org/10.1182/blood.V116.21.2007.2007

Published: 2010

Journal Articles

Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project.

Lisa M. Rimsza, MD, George Wright, Ph.D., Mark Schwartz, PhD, Wing C. Chan, Elaine S Jaffe, MD, Randy D. Gascoyne, MD, Elias Campo, MD, PhD, Andreas Rosenwald, MD, German Ott, MD, James R. Cook, MD, PhD, Raymond R. Tubbs, DO, Rita M. Braziel, MD, Jan Delabie, MD, Thomas P. Miller, MD, Richard I Fisher, MD, Louis M. Staudt, MD, PhD

Blood (2009) 114 (22): 620.

https://doi.org/10.1182/blood.V114.22.620.620

Published: 2009

Journal Articles

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Sarah T. Wilkinson, PhD, Roshanak Bob, MD, Harald Stein, MD, Mark Schwartz, PhD, Rita M. Braziel, MD, Randy D. Gascoyne, MD, Lisa M. Rimsza, MD

Blood (2009) 114 (22): 1941.

https://doi.org/10.1182/blood.V114.22.1941.1941

Published: 2009

Journal Articles

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Lisa M. Rimsza, Michael L. LeBlanc, Joseph M. Unger, Thomas P. Miller, Thomas M. Grogan, Daniel O. Persky, Ralph R. Martel, Constantine M. Sabalos, Bruce Seligmann, Rita M. Braziel, Elias Campo, Andreas Rosenwald, Joseph M. Connors, Laurie H. Sehn, Nathalie Johnson, Randy D. Gascoyne

Blood (2008) 112 (8): 3425–3433.

https://doi.org/10.1182/blood-2008-02-137372

Published: 2008

Includes: Supplemental data

Journal Articles

Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.

Lisa M. Rimsza, MD, Michael L. LeBlanc, PhD, Robin A. Roberts, BS, Joseph M. Unger, MS, Thomas P. Miller, MD, Constantine M. Sabalos, MS, Ralph R. Martel, PhD, Elias Campo, MD, Andreas Rosenwald, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Natalie Johnson, MD, Randy D. Gascoyne, MD

Blood (2007) 110 (11): 50.

https://doi.org/10.1182/blood.V110.11.50.50

Published: 2007

NARROW

Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study

Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay

Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project.

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.

Email alerts

ASH Publications

American Society of Hematology

Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study

Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay

Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project.

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only